Nemours Children's Hospital, Delaware is a pediatric hospital located in Wilmington, Delaware. It is controlled by the Nemours Foundation, a non-profit organization created by philanthropist Alfred I. du Pont in 1936 and dedicated to improving the health of children.

There are 208 beds in Alfred I duPont Hospital for Children.

During the past decade, Alfred I duPont Hospital for Children conducted 203 clinical trials. In the 10-year time frame, 203 clinical trials started and 134 clinical trials were completed, i.e. on average, 66% percent of trials that started reached the finish line to date. In the past 5 years, 87 clinical trials started and 62 clinical trials were completed. i.e. 71.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alfred I duPont Hospital for Children" #1 sponsor was "Children's Oncology Group" with 150 trials, followed by "National Cancer Institute (NCI)" with 63 trials sponsored, "Nemours Children's Clinic" with 30 trials sponsored, "BioMarin Pharmaceutical" with 6 trials sponsored and "Bristol-Myers Squibb" with 6 trials sponsored. Other sponsors include 152 different institutions and companies that sponsored additional 101 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alfred I duPont Hospital for Children" #1 collaborator was "National Cancer Institute (NCI)" with 157 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 14 trials as a collaborator, "Alfred I. duPont Hospital for Children" with 13 trials as a collaborator, "Children's Oncology Group" with 11 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 9 trials as a collaborator. Other collaborators include 275 different institutions and companies that were collaborators in the rest 202 trials.

According to Clinical.Site data, the most researched conditions in "Alfred I duPont Hospital for Children" are "Recurrent Neuroblastoma" (22 trials), "Recurrent Osteosarcoma" (19 trials), "Leukemia" (16 trials), "Sarcoma" (16 trials) and "Refractory Neuroblastoma" (15 trials). Many other conditions were trialed in "Alfred I duPont Hospital for Children" in a lesser frequency.

Most popular intervention types in "Alfred I duPont Hospital for Children" are "Drug" (257 trials), "Other" (143 trials), "Procedure" (101 trials), "Biological" (90 trials) and "Radiation" (63 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "Cyclophosphamide" (45 trials), "Vincristine Sulfate" (37 trials), "Etoposide" (33 trials) and "Questionnaire Administration" (32 trials). Other intervention names were less common.

The vast majority of trials in "Alfred I duPont Hospital for Children" are 403 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Alfred I duPont Hospital for Children". undefined are not yet recruiting, 87 are recruiting, 91 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 202 completed trials in Alfred I duPont Hospital for Children, 2 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Alfred I duPont Hospital for Children, 28 "Phase 1" clinical trials were conducted, 132 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 42 trials that are defined as “Not Applicable".